Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases.

Autor: Posado-Domínguez, L.^1,2 (AUTHOR) luisposado@usal.es, Chamorro, A.-J.^2,3,4 (AUTHOR), Del Barco-Morillo, E.^1,2,4 (AUTHOR), Martín-Galache, M.^2,5 (AUTHOR) luisposado@usal.es, Bueno-Sacristán, D.⁶ (AUTHOR), Fonseca-Sánchez, E.^1,2,4 (AUTHOR), Olivares-Hernández, A.^1,2 (AUTHOR) luisposado@usal.es

Publikováno v: Life (2075-1729). Jul2024, Vol. 14 Issue 7, p865. 14p.

Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50.

Autor: Olivares-Hernández A; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain., Posado-Domínguez L; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Redondo-González JC; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Corvo-Félix L; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Bellido Hernández L; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain., Fonseca-Sánchez E; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain., Del Barco-Morillo E; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2024 Oct 31; Vol. 13 (10), pp. 2649-2659. Date of Electronic Publication: 2024 Oct 24.

Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review.

Autor: Posado-Domínguez L; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Figuero-Pérez L; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Olivares-Hernández A; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Chinchilla-Tábora L; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Antunez-Plaza P; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Rivas-Hernández R; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Martín-Galache M; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Pediatric Department, University Hospital of Salamanca, Salamanca, Spain., Redondo González JC; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Fonseca Sánchez E; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Faculty of Medicine, University of Salamanca, Salamanca, Spain.

Publikováno v: Chinese clinical oncology [Chin Clin Oncol] 2024 Jun; Vol. 13 (3), pp. 42. Date of Electronic Publication: 2024 Jun 01.

Kaposi's Varicelliform Eruption: A Potentially Life-Threatening Complication of Atopic Dermatitis.

Autor: Martín-Galache M; Department of Paediatrics, University Hospital of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Escalona-Gil AM; Department of Paediatrics, University Hospital of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Posado-Domínguez L; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain., Jiménez-Domínguez A; Department of Paediatrics, University Hospital of Salamanca, Salamanca, Spain., Arévalo-Cenzual A; Department of Paediatrics, University Hospital of Salamanca, Salamanca, Spain., López-Ávila FJ; Department of Paediatrics, University Hospital of Salamanca, Salamanca, Spain.; Faculty of Medicine, University of Salamanca, Salamanca, Spain., Consuegra-Llapur E; Department of Paediatrics, University Hospital of Salamanca, Salamanca, Spain.; Paediatric Intensive Care Unit, University Hospital of Salamanca, Salamanca, Spain.

Publikováno v: European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2024 Mar 28; Vol. 11 (5), pp. 004392. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).

Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis.

Autor: Olivares-Hernández A; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Roldán-Ruiz J; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Miramontes-González JP; Department of Internal Medicine, University Hospital Rio Hortega, Valladolid, Spain; Faculty of Medicine, University of Valladolid, Valladolid, Spain., Toribio-García I; Department of Cardiology, University Hospital of Leon, León, Spain., García-Hernández JL; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Posado-Domínguez L; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Bellido-Hernández L; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Faculty of Salamanca, University of Salamanca, Salamanca, Spain., Cruz-Hernández JJ; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Faculty of Salamanca, University of Salamanca, Salamanca, Spain., Fonseca-Sánchez E; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Faculty of Salamanca, University of Salamanca, Salamanca, Spain., Del Barco-Morillo E; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Faculty of Salamanca, University of Salamanca, Salamanca, Spain.

Publikováno v: Chinese clinical oncology [Chin Clin Oncol] 2023 Dec; Vol. 12 (6), pp. 62.